Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has commenced its Phase 2a clinical trial for ATI-2138, an innovative oral covalent inhibitor targeting ITK and JAK3, aimed at treating moderate to …
Aclaris Therapeutics Launches Phase 2a Trial for ATI-2138 in Atopic Dermatitis Read More
WASHINGTON, D.C. — A recent report by the Centers for Disease Control and Prevention (CDC) reveals alarming trends in adult obesity rates across the United States. According to 2023 data, …
Shocking CDC Report Reveals Alarming Surge in Obesity Rates: Urgent Action Needed to Combat Health Crisis! Read More
WASHINGTON, D.C. — A recent Vital Signs report from the Centers for Disease Control and Prevention (CDC) highlights the significant influence that local conditions, such as health insurance coverage, broadband …
Local Conditions Unmasked: CDC Report Links Key Factors to Lower Suicide Rates Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled promising data from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in treating plantar fibromatosis, presented at the American Orthopaedic …
Endo, Inc. Highlights Promising Study Results for Plantar Fibromatosis Treatment Read More
COATESVILLE, PA — On Tuesday, as national and worldwide attention was focused on Philadelphia for the presidential debate, a local Equity Health Center (EHC) event in the city of Coatesville, …
Discover How a Local Event in Coatesville is Paving the Way for Health Equity—One Load of Laundry at a Time! Read More
PLYMOUTH MEETING, PA — Recent research published in the Journal of the National Comprehensive Cancer Network (JNCCN) proposes a significant shift in the administration of 5-fluorouracil (5-FU) for metastatic gastrointestinal (GI) …
New Study Suggests Revising 5-FU Administration in GI Cancer Treatments Read More
PHOENIXVILLE, PA — PleoPharma, Inc. has announced promising results from a Phase 2b study evaluating its leading drug candidate, PP-01, intended for mitigating Cannabis Withdrawal Syndrome. Conducted across 22 US addiction …
PleoPharma’s PP-01 Shows Promise in Treating Cannabis Withdrawal Syndrome Read More
KING OF PRUSSIA, PA — In observance of National Recovery Month, Recovery Centers of America (RCA) is spotlighting the crucial role of Medication for Addiction Treatment (MAT) in addressing substance use …
Discover How RCA’s Innovative Approach is Transforming Addiction Recovery Read More
MALVERN, PA — In recognition of Suicide Prevention Month, Neuronetics, Inc. (NASDAQ: STIM) is spotlighting the impactful stories shared on its NeuroStar Voices Portal. This platform, launched last year, allows individuals …
Neuronetics’ Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide Rates Read More
WASHINGTON, D.C. — U.S. Surgeon General Dr. Vivek Murthy recently issued a pressing advisory on the mental health and well-being of parents and caregivers. This call to action highlights the …
Parents in Crisis: Surgeon General’s Urgent Call to Protect Mental Health! Read More